关闭
About us

ABOUT GAUSH

Over 20 years of dedication to ophthalmology, empowering eye health with a full industrial chain

Company Profile

Gaush Meditech Ltd. (HKEX listed) is a leading ophthalmic enterprise in China, advancing eye health through strong R&D, comprehensive products, and exceptional service. Operating 6 global R&D centers, we offer 150+ products across all sub-specialties. Backed by 16 top international brand partnerships, our robust network reliably serves 5,000+ medical institutions, providing 29,000+ annual technical services and empowering 60,000+ professionals.


Guash Culture

  • Our Core Values
    Our Core Values

    Customer Orientation・Dedication・Integrity
    Open-mind・Teamwork・Self-reflection



  • Our Vision
    Our Vision

    To become a global leader in the ophthalmic device industry.

  • Our Mission
    Our Mission

    Technology creates a brighter vision.

Gaush Story

  • 1998: Establishment of Gaush

    1998: Establishment of Gaush

    Gaush was founded in Beijing, initially operating as a distributor. By introducing premier international ophthalmic products—such as ophthalmic ultrasound diagnostic systems and OCT devices—into the Chinese market, Gaush brought global-standard technologies to a vast population of ophthalmic patients in China.

  • 2007: Development of the Service Network and Gaush Online

    2007: Development of the Service Network and Gaush Online

    The company established a comprehensive technical service network covering the entirety of China. Concurrently, it launched "Gaush Online" (G-Webinar), creating a professional scientific education platform for the industry.

  • 2017: Acquisition of Raymond

    2017: Acquisition of Raymond

    Gaush embarked on its path of proprietary research and development (R&D), expanding its business into the manufacturing of optometric examination equipment.

  • 2020 & 2021: Acquisitions of Teleon and Roland Consult

    2020 & 2021: Acquisitions of Teleon and Roland Consult

    Gaush acquired Roland Consult in Germany, initiating its strategic global layout in the ophthalmic electrophysiology business.It also acquired Teleon Surgical in the Netherlands, expanding its global footprint into the premium cataract surgery and intraocular lens (IOL) sectors.

  • 2022: HKEX Listing

    2022: HKEX Listing

    Gaush was successfully listed on the Main Board of the Stock Exchange of Hong Kong. Meanwhile, it established multiple R&D bases in China (including Wuxi), continuously bolstering its independent innovation and R&D capabilities.

  • Present: Global Footprint & Internationalization

    Present: Global Footprint & Internationalization

    While maintaining close cooperation with international brand partners, Gaush has been actively driving the global rollout of its self-developed products, committed to bringing Gaush's innovations to patients and healthcare professionals worldwide.

COPYRIGHT©2022-2026 Gaush Meditech Ltd. All Rights Reserved.  Sitemap ICP:ICP 05025558-2